Eculizumab was safe and effective in the management of transplant-associated thrombotic microangiopathy in a heart transplant recipient with concurrent COVID-19 infection

Internal medicine journal(2023)

引用 0|浏览4
暂无评分
关键词
thrombotic microangiopathy,heart transplant‐associated recipient
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要